Label Creation and Application. 10.1.1 AMGEN will be responsible for labeling of Product that will be distributed to COMPANY according to AMGEN procedures. The label will include the following information: cautionary statement, Amgen artwork number, manufacturing date and drug product batch number. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Appears in 3 contracts
Samples: Exclusive License Agreement (Atara Biotherapeutics, Inc.), Exclusive License Agreement (Atara Biotherapeutics, Inc.), Exclusive License Agreement (Atara Biotherapeutics, Inc.)
Label Creation and Application. 10.1.1 AMGEN will be responsible for labeling of Product that will be distributed to COMPANY according to AMGEN procedures. The label will include the following information: cautionary statement, Amgen artwork number, manufacturing date and drug product batch number. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Appears in 3 contracts
Samples: Exclusive License Agreement (Atara Biotherapeutics, Inc.), Exclusive License Agreement (Atara Biotherapeutics, Inc.), Exclusive License Agreement (Atara Biotherapeutics, Inc.)